Technical Analysis for CODX - Co-Diagnostics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 1.26 | 0.80% | 0.01 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Support | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| NR7 | Range Contraction | 0.80% | |
| Inside Day | Range Contraction | 0.80% | |
| Wide Bands | Range Expansion | 0.80% | |
| Down 3 Days in a Row | Weakness | 0.80% |
| Alert | Time |
|---|---|
| Possible NR7 | about 6 hours ago |
| 1.5x Volume Pace | about 10 hours ago |
| 50 DMA Resistance | about 10 hours ago |
| Fell Below 50 DMA | about 10 hours ago |
| 50 DMA Support | about 10 hours ago |
Get a Trading Assistant
- Earnings date: 05/09/2024
Co-Diagnostics, Inc. Description
Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Clinical Medicine Disease Acid Medical Test Hepatitis B Diagnostic Tests Molecular Diagnostics Genetic Diseases Immunodeficiency Malaria Organisms Diagnostic Equipment Polymerase Chain Reaction Tuberculosis Ortho Clinical Diagnostics Dengue Zika Dengue Fever
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.88 |
| 52 Week Low | 0.9811 |
| Average Volume | 139,034 |
| 200-Day Moving Average | 1.19 |
| 50-Day Moving Average | 1.22 |
| 20-Day Moving Average | 1.36 |
| 10-Day Moving Average | 1.37 |
| Average True Range | 0.15 |
| RSI (14) | 47.37 |
| ADX | 28.17 |
| +DI | 16.50 |
| -DI | 16.38 |
| Chandelier Exit (Long, 3 ATRs) | 1.29 |
| Chandelier Exit (Short, 3 ATRs) | 1.44 |
| Upper Bollinger Bands | 1.70 |
| Lower Bollinger Band | 1.02 |
| Percent B (%b) | 0.35 |
| BandWidth | 50.31 |
| MACD Line | 0.03 |
| MACD Signal Line | 0.06 |
| MACD Histogram | -0.031 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.38 | ||||
| Resistance 3 (R3) | 1.37 | 1.33 | 1.36 | ||
| Resistance 2 (R2) | 1.33 | 1.30 | 1.33 | 1.35 | |
| Resistance 1 (R1) | 1.29 | 1.28 | 1.31 | 1.30 | 1.35 |
| Pivot Point | 1.25 | 1.25 | 1.26 | 1.25 | 1.25 |
| Support 1 (S1) | 1.21 | 1.22 | 1.23 | 1.22 | 1.17 |
| Support 2 (S2) | 1.17 | 1.20 | 1.17 | 1.17 | |
| Support 3 (S3) | 1.13 | 1.17 | 1.16 | ||
| Support 4 (S4) | 1.14 |
